Study on the Use of Avelumab Plus Talazoparib in Patients With Locally Advanced or Metastatic Solid Tumors
Study on the Use of Avelumab Plus Talazoparib in Patients With Locally
Advanced or Metastatic Solid Tumors. A Phase 1b/2 Study to Evaluate Safety and Anti-Tumor Activity of Avelumab in Combination With the Poly (Adenosine Diphosphate (ADP)-Ribose) Polymerase (PARP) Inhibitor Talazoparib in Patients With Locally Advanced or Metastatic Solid Tumors.
Category & Conditions: Cancer
Medicine: Bavencio (avelumab)
Talzenna (talazoparib)
ClinicalTrials.gov Identifier (NCT): NCT03330405
Protocol ID: B9991025
PrintDownloadOpen Plain Language Summary Result: Click here